179 related articles for article (PubMed ID: 27749218)
1. Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.
Balarini GM; Zandonade E; Tanure L; Ferreira GA; Sardenberg WM; Serrano ÉV; Dias CC; Navarro TP; Nordal HH; Mydel PM; Brun JG; Brokstad KA; Gerdts E; Jonsson R; Valim V
Clin Exp Rheumatol; 2016; 34(6):1006-1012. PubMed ID: 27749218
[TBL] [Abstract][Full Text] [Related]
2. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.
Zhang Y; Luo Q; Lu K; You M; Wang H
Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944
[TBL] [Abstract][Full Text] [Related]
3. Levels of Vitamin D, Disease Activity and Subclinical Atherosclerosis in Post-menopausal Women with Sjögren's Syndrome: Does a Link Exist?
Zardi EM; Basta F; Afeltra A
In Vivo; 2016 09-10; 30(5):721-5. PubMed ID: 27566098
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
5. Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairment.
Karageorgas T; Ioakeimidis D; Mavragani CP
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):68-72. PubMed ID: 29148412
[TBL] [Abstract][Full Text] [Related]
6. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.
Gravani F; Papadaki I; Antypa E; Nezos A; Masselou K; Ioakeimidis D; Koutsilieris M; Moutsopoulos HM; Mavragani CP
Arthritis Res Ther; 2015 Apr; 17(1):99. PubMed ID: 25886059
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
Andréasson K; Ohlsson B; Mandl T
Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.
Ozisler C; Kaplanoglu H
Clin Rheumatol; 2019 Mar; 38(3):709-717. PubMed ID: 30334118
[TBL] [Abstract][Full Text] [Related]
9. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
10. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.
Valim V; Gerdts E; Jonsson R; Ferreira GA; Brokstad KA; Brun JG; Midtbø H; Mydel PM
Clin Exp Rheumatol; 2016; 34(1):133-42. PubMed ID: 26812164
[TBL] [Abstract][Full Text] [Related]
12. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
14. Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjögren's syndrome.
Nordal HH; Brun JG; Halse AK; Madland TM; Fagerhol MK; Jonsson R
Scand J Rheumatol; 2014; 43(1):76-8. PubMed ID: 24295066
[No Abstract] [Full Text] [Related]
15. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
Choi BY; Oh HJ; Lee YJ; Song YW
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.
Zhang R; Sun T; Song L; Zuo D; Xiao W
Cytokine; 2014 Oct; 69(2):289-93. PubMed ID: 24981072
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
[TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C is not an appropriate marker for kidney involvement in patients with primary Sjögren's syndrome.
Altunoğlu A; Erten Ş; Şahin A; Işıkoğlu S; Neşelioğlu S; Erzurum C; Erel Ö
Int J Rheum Dis; 2017 Mar; 20(3):371-375. PubMed ID: 25367815
[TBL] [Abstract][Full Text] [Related]
20. Presence of enthesopathy in patients with primary Sjogren's syndrome: ultrasonographic study of a local cohort.
Sag S; Sag MS; Tekeoglu I; Kamanlı A; Nas K
J Med Ultrason (2001); 2018 Jan; 45(1):121-127. PubMed ID: 28646319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
